Deflated or defeated? Is brilacidin done? Or did one out of three of it's potential blockbuster angles just get flushed leaving two more legs of the pipeline intact? As far as I can tell the anti-bacterial and inflammatory legs are still there. I expect Leo will somehow make them seem like they will take over the market share and make IPIX shareholders millionaires.
I'm not shy to say I sold out back in November and have done quite well for the most part swinging IPIX over the years. The OTC is ripe with opportunity to play the angles of the hype surrounding these companies. I think Leo's been laying low figuring out his next move. I have a couple theories. One is that he'll dilute into oblivion (thinking we'll easily crack 1 B outstanding by mid summer) and sell the company to someone who won't hesitate to pull a RS and start the game all over again under their own new name. The second is he'll try to further push brilacidin and get the bandwagon rolling with ever more enthusiasm. And possibly bring in yet another name in the industry.

Either way, I think we'll see his move in the next week or three.